Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05562349 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clavulanic Acid for the Treatment of Cocaine Use Disorder

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 2, 2024 (before its estimated July 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Jan 2024 to Jul 2024
    • Study completion date: Feb 2024 to Jul 2024
    • Site details revised at 2 of 2 sites
    v9
  2. Start date changed from estimate of May 2023 to May 3, 2023v8
  3. Start date: Apr 10, 2023 to May 2023v7
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Feb 28, 2023 to Apr 10, 2023
    • Study sites: 0 to 2
    • Eligibility criteria expanded, about 4 words
    v6
  5. Start date: Jan 2023 to Feb 28, 2023v5
Show 3 earlier versionsHide 3 earlier versions
  1. Study completion date: Jan 2024 to Feb 2024v4
  2. Primary completion date: Dec 2023 to Jan 2024
    • Study completion date: Mar 2024 to Jan 2024
    • Secondary endpoints: details revised at 1 of 5 entries
    v3
  3. Start date: Oct 2022 to Jan 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A dose escalation study to assess the efficacy and safety of Clavulanic Acid (CLAV) vs. placebo (PBO) for the treatment of cocaine use disorder (CUD)
Trial Details
NCT Number NCT05562349
Lead Sponsor Temple University
Collaborators: University of Pennsylvania, Medical University of South Carolina, Research Foundation for Mental Hygiene, Inc.
Conditions
(from sponsor)		 Cocaine Dependence
Related terms Cocaine-Related Disorders
Enrollment 65 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov